drugset / Trial / NCT00000448

Naltrexone Treatment for Alcoholic Women

NCT00000448

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess naltrexone's effectiveness in treating alcoholism in women and provide information on its potential value in treating eating disorders common among alcoholic women. Alcoholic women with and without both eating disorders and depression will be randomly assigned to placebo or naltrexone treatment. Each group will receive behavioral therapy for 12 weeks, with followup 6 months after treatment.

Timeline

Start
1995-10
Primary completion
2000-12
Completion
2000-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 50 mg